500 patients67,039 observations150 daysLIVE

Patient P-03104

Synthetic patientONX-7 · Day 139 · 65–74 · M · baseline S14Open companion preview
Therapy response
Unstable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
20%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S14
  2. Day 26 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 86 AD-05 recommendedAdherence Support AD-05
  4. Day 87 Patient acceptedStarted AD-05 in the companion
  5. Day 92 No meaningful changeAdherence Support AD-05

What changed?

Trajectory began diverging from predicted response on Day 26.

Primary contributors, last 14 days
  • Toxicity+9
  • GI instability-5
  • Nutritional resilience-3
  • Treatment adherence+3

What helped?

  • Adherence Support AD-05Day 86
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Drug metabolism and exposure 40
    • DNACYP2D6 poor metabolizer → higher exposure
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • CYP2D6 Poor metabolizer
    Higher exposure at standard dose
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 3.3 · butyrate capacity 78/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
65 ms
Sleep
7.8 h
Steps
9,491
Resting HR
60 bpm
Daily log: GI score 11, nutritional resilience 66, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Keep fibre steady; no new sources this week
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0340053%S2031
P-0303952%S1028
P-0327352%S1437
P-0339552%S0326
P-0340952%S1228
P-0316851%S2020
P-0327851%S1927
P-0333051%S1024
P-0307750%S0228
P-0308850%S0636
P-0301549%S1929
P-0315049%S0521